60 Degrees Pharmaceuticals, Inc.
SXTP
$1.41
$0.118.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 973.70K | 791.50K | 670.50K | 451.80K | 430.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 973.70K | 791.50K | 670.50K | 451.80K | 430.50K |
| Cost of Revenue | 805.40K | 3.69M | 3.61M | 4.39M | 3.67M |
| Gross Profit | 168.30K | -2.90M | -2.94M | -3.93M | -3.24M |
| SG&A Expenses | 6.12M | 5.64M | 5.03M | 5.11M | 5.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.68M | 11.09M | 10.40M | 10.00M | 9.38M |
| Operating Income | -7.71M | -10.29M | -9.73M | -9.54M | -8.95M |
| Income Before Tax | -7.82M | -10.26M | -7.96M | -7.95M | -1.62M |
| Income Tax Expenses | 1.40K | 300.00 | 300.00 | 900.00 | 700.00 |
| Earnings from Continuing Operations | -7.82 | -10.26 | -7.96 | -7.95 | -1.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.60K | 6.90K | 8.60K | 38.60K | 47.60K |
| Net Income | -7.82M | -10.25M | -7.95M | -7.91M | -1.57M |
| EBIT | -7.71M | -10.29M | -9.73M | -9.54M | -8.95M |
| EBITDA | -7.64M | -10.24M | -9.68M | -9.50M | -8.90M |
| EPS Basic | -9.75 | -29.63 | -26.22 | -45.91 | 4.28 |
| Normalized Basic EPS | -5.75 | -17.86 | -15.34 | -26.53 | -34.40 |
| EPS Diluted | -9.75 | -29.63 | -26.22 | -45.91 | 4.28 |
| Normalized Diluted EPS | -5.75 | -17.86 | -15.34 | -26.53 | -34.40 |
| Average Basic Shares Outstanding | 4.20M | 2.93M | 1.82M | 957.40K | 558.40K |
| Average Diluted Shares Outstanding | 4.20M | 2.93M | 1.82M | 957.40K | 558.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |